Minxuan Y. Sun
Suzhou, 215163, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Defective m6A RNA Modification in Macrophages Exacerbates Inflammation and Promotes Colitis-Associated Carcinogenesis by Impairing Efferocytosis.
Journal: Cancer letters
Published: June 09, 2026
Arachidonic acid promotes M2-like polarization of tumor-associated macrophages and glioma progression.
Journal: International immunopharmacology
Published: May 11, 2026
Trehalose-driven TFEB Activation Reprograms Immunosuppressive Macrophages in Glioblastoma.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 17, 2026
Macrophage NPM1 drives anti-tumor immunity via the STAT3-CCRL2 axis.
Journal: Frontiers in immunology
Published: November 18, 2025
High expression of SENP1 correlates with poor prognosis and immune evasion in gastric cancer.
Journal: International immunopharmacology
Published: August 07, 2025
Membrane Encapsulated Fe3O4@MnO@cGAMP Nanocatalyst for Cancer Therapy: cGAS-STING Immune Pathway Activation.
Journal: Advanced healthcare materials
Published: March 26, 2025
GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches.
Journal: Biomedicines
Published: December 28, 2024
Morusin regulates the migration of M2 macrophages and GBM cells through the CCL4-CCR5 axis.
Journal: International immunopharmacology
Published: October 01, 2024
Multi-transcriptomics reveals niche-specific expression programs and endothelial cells in glioblastoma.
Journal: Journal of translational medicine
Published: May 01, 2024
LPS exposure alleviates multiple tissues damage by facilitating macrophage efferocytosis.
Journal: International immunopharmacology
Published: April 02, 2024
MiR-146a alleviates inflammatory bowel disease in mice through systematic regulation of multiple genetic networks.
Journal: Frontiers in immunology
Published: January 06, 2024
Mineralocorticoid promotes intestinal inflammation through receptor dependent IL17 production in ILC3s.
Journal: International immunopharmacology
Published: December 11, 2023
Last Updated: 09/26/2026